JAMP Pharma Sodium Phosphate 500 mg 20 Tablets

JAMP Pharma Sodium Phosphate 500 mg is an oral effervescent tablet for people using it on a physician’s advice. Its Health Canada licensed use is: "Hypercalciuria, electrolyte replenisher."

This product comes as 20 effervescent tablets for oral solution. Each tablet contains phosphorus 500 mg, potassium 123 mg, and sodium 469 mg. Dissolve a tablet in water before taking it and follow the label directions.

Features

• Effervescent tablets for oral solution
• Phosphorus 500 mg per tablet
• 20 tablets per package
• Licensed use: "Hypercalciuria, electrolyte replenisher"
• Contains potassium 123 mg and sodium 469 mg

Directions

Take 1 tablet 1-2 times daily. Take tablets only when dissolved in water. Use preferably 250 mL of diluent. Use only on the advice of a physician. Adjust dose according to patient response. Warnings DO NOT USE IF SEAL IS BROKEN OR MISSING.

Read and follow the label.

Ingredients

Medicinal: Phosphorus 500mg, Potassium 123mg, Sodium 469mg

Non-medicinal: simethicone, Povidone K-30, Orange flavour, Sodium benzoate, Citric Acid Anhydrous, Saccharin sodium

Warnings

Consult a healthcare practitioner prior to use if you have a cardiac disease treated with digitalis, adrenal insufficiency, acute dehydration, severe renal insufficiency, cardiac failure, liver cirrhosis or severe hepatic disease, edema, hypernatremia, hypertension or toxaemia of pregnancy. Do not use if hyperphosphatemia is present or in the presence of severe impairment of renal function (less than 30% of normal). KNOWN ADVERSE REACTIONS: The following reactions have been reported: Nausea, vomiting, stomach pain, laxative effect or diarrhea, and less frequently: Fluid retention associated with swelling of feet and/or weight gain, hyperkalemia associated with confusion, tiredness or weakness; irregular or slow heart beat; numbness or tingling around lips, hands or feet; unexplained anxiety; breathing problems, hypernatremia associated with confusion; tiredness or weakness; convulsions; decrease in urine volume or in frequency of urine; fast heartbeat; headache or dizziness; increased thirst; hyperphosphatemia or hypocalcemic tetany associated with muscle cramps; numbness, tingling, pain, or weakness in hands or feet, shortness of breath or troubled breathing. KEEP OUT OF REACH AND SIGHT OF CHILDREN.